A multi-center clinical study on treatment of severe neuroimmune diseases with short-term blood purification and sequential reduction of intravenous immunoglobulin

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2022
This article has no abstract
Epistemonikos ID: 07256da2b00e7c08e3531c3cc209d8a6e55f40d2
First added on: Apr 08, 2025